Pliant Therapeutics Financial Overview
Pliant Therapeutics's market cap is currently $98.83M. The company's EPS TTM is $-0.43; its P/E ratio is -0.47; Pliant Therapeutics is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is $-0.40. See an overview of income statement, balance sheet, and cash flow financials.
